Literature summary for 4.2.2.1 extracted from

Ozegowski, J.H.; Presselt, N.; Haertl, A.; Bocker, T.; Saenger, J.; Schmidt, A.; Willing, K.; Mueller, P.J.
Anti-atherosclerotic effect of microbial hyaluronate lyase from group B streptococci (2008), Pharmazie, 63, 601-605.

Search for more literature for 4.2.2.1

Application

Application	Comment	Organism
pharmacology	in vitro microbial hyaluronate lyase is able to split the hyaluronic acid in atherosclerotic plaques under release of calcium deposits and reduces in vivo the development of atherosclerotic lesions in hyperlipidaemic rabbits	Streptococcus agalactiae

Organism

Organism	UniProt	Comment	Textmining
Streptococcus agalactiae	O86478	strain group B	-

Purification (Commentary)

Purification (Comment)	Organism
-	Streptococcus agalactiae

Source Tissue

Source Tissue	Comment	Organism	Textmining

Specific Activity [micromol/min/mg]

Specific Activity Minimum [µmol/min/mg]	Specific Activity Maximum [µmol/min/mg]	Comment	Organism
400000	-	stabilized by addition of 5 mg ovalbumin/mg hyaluronate lyase	Streptococcus agalactiae

Synonyms

Synonyms	Comment	Organism
hyaluronate lyase	-	Streptococcus agalactiae

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)